Michael R. Bishop, M.D.
Director of the Hematopoietic Cellular Therapy Program, Director of the David and Etta Jonas Center for Cellular Therapy, and Professor of Medicine at the University of Chicago
Dr. Bishop is the Director of the Hematopoietic Cellular Therapy Program, Director of the David and Etta Jonas Center for Cellular Therapy, and Professor of Medicine at the University of Chicago. Dr. Bishop joined the National Cancer Institute in March 1999 to serve as the Clinical Head of the Stem Cell Transplantation Program. In 2003, he received the National Institutes of Health Distinguished Clinical Teacher Award. He received tenure as Senior Investigator at NIH in 2007. In 2009 he organized and co-chaired the First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation. In 2011 Dr. Bishop’s was appointed as Head of the Hematologic Malignancies Section in the Division of Hematology and Oncology at the Medical College of Wisconsin/Froedtert Hospital in Milwaukee. In 2012, Dr. Bishop was recruited to serve as the director of the University of Chicago Hematopoietic Stem Cell Transplantation Program and was appointed Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine at the University of Chicago. In 2013, Dr. Bishop was named a Bucksbaum Institute for Clinical Excellence Master Clinician. In 2020, Dr. Bishop was named the Director of the David and Etta Jonas Center for Cellular Therapy at the University of Chicago.
Dr. Bishop’s research focuses on the development and conducting of novel clinical trials in hematopoietic stem cell transplantation and cellular therapy. Particular areas of interest include the therapeutic use of T cells to treat hematologic malignancies and solid tumors. In addition, his research program is focused on methods to prevent and treat recurrent disease following hematopoietic stem cell transplantation, with a primary focus on B-cell malignancies, as well as myeloma and leukemia.
Dr. Bishop has authored or co-authored over 200 peer-reviewed articles in journals such as New England Journal of Medicine, Lancet, Journal of Clinical Oncology, and Blood and over 35 book chapters relative to the fields of hematologic malignancies, hematopoietic stem cell transplantation, and cellular therapy. He serves as a reviewer and on the editorial boards of numerous scientific journals including New England Journal of Medicine, Journal of Clinical Oncology, Blood, Journal for ImmunoTherapy of Cancer, and Biology of Blood and Marrow Transplantation.
Dr. Bishop received his M.D. from the University of Illinois in 1985. He completed clinical training in internal medicine at Northwestern University in 1988 and a fellowship in hematology and oncology at Loyola University Medical Center in 1991. He was an assistant professor of medicine at the University of Kentucky Medical Center from 1991 to 1992 and an associate professor of medicine at the University of Nebraska Medical Center from 1992 to 1999, where he served as director of the Leukemia and Allogeneic Stem Cell Transplantation Programs.